ONDINE BIOPHARMA

PHARMACEUTICALS, NAMELY, PHARMACEUTICALS FOR THE TREATMENT OF INFECTIOUS DISEASES; PHARMACEUTICALS FOR THE TREATMENT OF TOPICAL INFECTIOUS DISEASES; LIGHT-ACTIVATED COMPOSITIONS FOR TOPICAL USE FOR KILLING DISEASE-CAUSING MICRO-ORGANISMS AND LIGHT-ACTIVATED COMPOSITIONS FOR ORAL USE FOR KILLING DISEASE-CAUSING MICRO-ORGANISMS